Affecting hundreds of millions of people, chronic hepatitis B is a widespread global health problem for which there is as yet no cure. In a preclinical study involving the German Center for Infection Research (DZIF), Heidelberg ...
Aug 4, 2023
0
14
Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, have published a new study explaining how they took a protein once thought to be too challenging for targeted ...
Aug 1, 2023
0
200
People with an impaired immune system can achieve a relatively robust response against SARS-CoV-2 if they get a booster shot, scientists in Sweden have found in a clinical trial that administered extra mRNA shots to patients ...
Parents in the U.S. can breathe a sigh of relief: The FDA has approved a new drug that can protect infants and toddlers from RSV (respiratory syncytial virus) throughout the virus season.
Jul 28, 2023
0
1
Exceptionally potent antibodies that can neutralize virtually all known variants of the COVID-19 virus—including omicron, as well as other dangerous animal coronaviruses that could potentially cause future outbreaks—have ...
Jul 28, 2023
0
338
New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease. To help neurologists discuss these ...
Jul 27, 2023
0
1
A new technology developed at Caltech is designed to make more potent vaccines, beginning with SARS-CoV-2 (the virus that causes COVID-19). In mouse studies, the prototype vaccine elicited five times more antibodies than ...
Jul 25, 2023
0
42
The first ever clinical trial of a new class of immunotherapy for cancer has shown promising results that could benefit patients who do not respond to existing cancer treatments.
Jul 25, 2023
0
43
Booster vaccinations (third and fourth vaccinations) of COVID-19 mRNA vaccines that are not adapted to omicron variants do lead to higher blood levels of neutralizing antibodies against the omicron subvariants. However, these ...
Jul 20, 2023
0
20
Trial results of a new drug to treat Alzheimer's disease, donanemab, shows it can slow cognitive decline by 35%. The drug has been hailed as a "turning point" in Alzheimer's treatment.
Jul 19, 2023
0
7
